Version 2.78

Term Description

Newborn screening dried blood spot analysis by tandem mass spectrometry (MS/MS) requires pre-processing the specimen with one of two alternative reagent methods referred to as derivatized and non-derivatized (or underivatized) methods. The methods are similar and nearly all analytes and ratios are identical with the limited number of exceptions noted in the description of the LOINC codes. Some labs choose to use the non-derivatized method because it may be faster or less expensive for their operations. There are no analytes which would be interpreted differently based on the method used to process the specimen so there is no need for different LOINC codes for the same compounds based on the reagents. In a few cases, a different LOINC code is used for the derivatized or non-derivatized tandem mass spectrometry (MS/MS) method because based on the reagents used in processing, different analytes are measured or different sets of analytes become isobaric, which means that they cannot be distinguished on the MS/MS because they have the same molecular weight after reagent processing.
Source: Regenstrief LOINC

Panel Hierarchy

Details for each LOINC in Panel LHC-Forms

LOINC Name R/O/C Cardinality Example UCUM Units
57084-6 Fatty acid oxidation newborn screen panel C
Indent46736-5 Fatty acid oxidation defects newborn screen interpretation C
Indent57792-4 Fatty acid oxidation conditions suspected [Identifier] in DBS C
Indent57709-8 Fatty acid oxidation defects newborn screening comment-discussion C
Indent38481-8 Carnitine free (C0) [Moles/volume] in DBS C umol/L
Indent53233-3 Carnitine free (C0)/Palmitoylcarnitine (C16) [Molar ratio] in DBS C {Ratio}
Indent53234-1 Carnitine free (C0)/Stearoylcarnitine (C18) [Molar ratio] in DBS C {Ratio}
Indent53235-8 Carnitine free (C0)/Palmitoylcarnitine (C16)+Stearoylcarnitine (C18) [Molar ratio] in DBS C {Ratio}
Indent53236-6 Carnitine.free (C0)+Acetylcarnitine (C2)+Propionylcarnitine (C3)+Palmitoylcarnitine (C16)+Oleoylcarnitine (C18:1)+Stearoylcarnitine (C18)/Citrulline [Molar ratio] in DBS C {Ratio}
Indent75211-3 Propionylcarnitine (C3)+Palmitoylcarnitine (C16) [Moles/volume] in DBS C umol/L
Indent75212-1 Malonylcarnitine (C3-DC)/Decanoylcarnitine (C10) [Molar ratio] in DBS C {ratio}
Indent54462-7 Malonylcarnitine (C3-DC) [Moles/volume] in DBS C umol/L
Indent75213-9 Malonylcarnitine (C3-DC)+3-Hydroxybutyrylcarnitine (C4-OH)/Decanoylcarnitine (C10) [Molar ratio] in DBS C {ratio}
Indent50157-7 Acetylcarnitine (C2) [Moles/volume] in DBS C umol/L
Indent53166-5 Butyrylcarnitine+Isobutyrylcarnitine (C4) [Moles/volume] in DBS C umol/L
Indent53167-3 Butyrylcarnitine+Isobutyrylcarnitine (C4)/Acetylcarnitine (C2) [Molar ratio] in DBS C {Ratio}
Indent53168-1 Butyrylcarnitine+Isobutyrylcarnitine (C4)/Propionylcarnitine (C3) [Molar ratio] in DBS C {Ratio}
Indent53169-9 Butyrylcarnitine+Isobutyrylcarnitine (C4)/Octanoylcarnitine (C8) [Molar ratio] in DBS C {Ratio}
Indent50102-3 3-Hydroxybutyrylcarnitine (C4-OH) [Moles/volume] in DBS C umol/L
Indent45211-0 Hexanoylcarnitine (C6) [Moles/volume] in DBS C umol/L
Indent53173-1 3-Hydroxyhexanoylcarnitine (C6-OH) [Moles/volume] in DBS C umol/L
Indent45207-8 Glutarylcarnitine (C5-DC) [Moles/volume] in DBS C umol/L
Indent53174-9 Octenoylcarnitine (C8:1) [Moles/volume] in DBS C umol/L
Indent53175-6 Octanoylcarnitine (C8) [Moles/volume] in DBS C umol/L
Indent53176-4 Octanoylcarnitine (C8)/Acetylcarnitine (C2) [Molar ratio] in DBS C {Ratio}
Indent53177-2 Octanoylcarnitine (C8)/Decanoylcarnitine (C10) [Molar ratio] in DBS C {Ratio}
Indent53178-0 3-Hydroxyoctanoylcarnitine (C8-OH)+Malonylcarnitine (C3-DC) [Moles/volume] in DBS C umol/L
Indent53402-4 3-Hydroxyoctanoylcarnitine (C8-OH)+Malonylcarnitine (C3-DC)/Butyrylcarnitine+Isobutyrylcarnitine (C4) [Molar ratio] in DBS C {Ratio}
Indent53179-8 3-Hydroxyoctanoylcarnitine (C8-OH)+Malonylcarnitine (C3-DC)/Decanoylcarnitine (C10) [Molar ratio] in DBS C {Ratio}
Indent53180-6 Decadienoylcarnitine (C10:2) [Moles/volume] in DBS C umol/L
Indent45198-9 Decenoylcarnitine (C10:1) [Moles/volume] in DBS C umol/L
Indent45197-1 Decanoylcarnitine (C10) [Moles/volume] in DBS C umol/L
Indent53182-2 3-Hydroxydecenoylcarnitine (C10:1-OH) [Moles/volume] in DBS C umol/L
Indent53183-0 Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH) [Moles/volume] in DBS C umol/L
Indent53403-2 Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Butyrylcarnitine+Isobutyrylcarnitine (C4) [Molar ratio] in DBS C {Ratio}
Indent53184-8 Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/3-Hydroxyisovalerylcarnitine (C5-OH) [Molar ratio] in DBS C {Ratio}
Indent53185-5 Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Octanoylcarnitine (C8) [Molar ratio] in DBS C {Ratio}
Indent53186-3 Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Palmitoylcarnitine (C16) [Molar ratio] in DBS C {Ratio}
Indent45200-3 Dodecenoylcarnitine (C12:1) [Moles/volume] in DBS C umol/L
Indent45199-7 Dodecanoylcarnitine (C12) [Moles/volume] in DBS C umol/L
Indent53188-9 3-Hydroxydodecenoylcarnitine (C12:1-OH) [Moles/volume] in DBS C umol/L
Indent53189-7 3-Hydroxydodecanoylcarnitine (C12-OH) [Moles/volume] in DBS C umol/L
Indent53190-5 Tetradecadienoylcarnitine (C14:2) [Moles/volume] in DBS C umol/L
Indent53191-3 Tetradecenoylcarnitine (C14:1) [Moles/volume] in DBS C umol/L
Indent53192-1 Tetradecanoylcarnitine (C14) [Moles/volume] in DBS C umol/L
Indent53193-9 Tetradecenoylcarnitine (C14:1)/Acetylcarnitine (C2) [Molar ratio] in DBS C {Ratio}
Indent53194-7 Tetradecenoylcarnitine (C14:1)/Dodecenoylcarnitine (C12:1) [Molar ratio] in DBS C {Ratio}
Indent53195-4 Tetradecenoylcarnitine (C14:1)/Palmitoylcarnitine (C16) [Molar ratio] in DBS C {Ratio}
Indent70159-9 Tetradecenoylcarnitine (C14:1)/Tetradecanoylcarnitine (C14) [Molar ratio] in DBS C {ratio}
Indent53196-2 3-Hydroxytetradecadienoylcarnitine (C14:2-OH) [Moles/volume] in DBS C umol/L
Indent53197-0 3-Hydroxytetradecenoylcarnitine (C14:1-OH) [Moles/volume] in DBS C umol/L
Indent50281-5 3-Hydroxytetradecanoylcarnitine (C14-OH) [Moles/volume] in DBS C umol/L
Indent53198-8 Palmitoleylcarnitine (C16:1) [Moles/volume] in DBS C umol/L
Indent53199-6 Palmitoylcarnitine (C16) [Moles/volume] in DBS C umol/L
Indent50121-3 3-Hydroxypalmitoleylcarnitine (C16:1-OH) [Moles/volume] in DBS C umol/L
Indent50125-4 3-Hydroxypalmitoylcarnitine (C16-OH) [Moles/volume] in DBS C umol/L
Indent53201-0 3-Hydroxypalmitoylcarnitine (C16-OH)/Palmitoylcarnitine (C16) [Molar ratio] in DBS C {Ratio}
Indent45217-7 Linoleoylcarnitine (C18:2) [Moles/volume] in DBS C umol/L
Indent53202-8 Oleoylcarnitine (C18:1) [Moles/volume] in DBS C umol/L
Indent53241-6 Stearoylcarnitine (C18) [Moles/volume] in DBS C umol/L
Indent53400-8 Stearoylcarnitine (C18)/Propionylcarnitine (C3) [Molar ratio] in DBS C {Ratio}
Indent50109-8 3-Hydroxylinoleoylcarnitine (C18:2-OH) [Moles/volume] in DBS C umol/L
Indent50113-0 3-Hydroxyoleoylcarnitine (C18:1-OH) [Moles/volume] in DBS C umol/L
Indent50132-0 3-Hydroxystearoylcarnitine (C18-OH) [Moles/volume] in DBS C umol/L
Indent53836-3 ABCD1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method

Fully-Specified Name

Component
Fatty acid oxidation newborn screen panel
Property
-
Time
Pt
System
Bld.dot
Scale
-
Method

Additional Names

Short Name
FA oxidation NB scn pnl DBS
Display Name
Fatty acid oxidation NBS panel (DBS)
Consumer Name Alpha Get Info
Fatty Acid Oxidation NBS Panel, Dried blood spot

Basic Attributes

Class
PANEL.CHEM
Type
Laboratory
First Released
Version 2.29
Last Updated
Version 2.77
Order vs. Observation
Order
Common Test Rank Get Info
17172
Panel Type
Panel

Member of these Panels

LOINC Long Common Name
58092-8 Acylcarnitine newborn screen panel
104191-2 Guanidinoacetate methyltransferase (GAMT) deficiency newborn screening panel
54089-8 Newborn screening panel American Health Information Community (AHIC)

Language Variants Get Info

Tag Language Translation
es-MX Spanish (Mexico) Panel de pantalla recién nacido de oxidación de ácidos grasos:-:Punto temporal:DBS:-:
es-ES Spanish (Spain) Panel de cribado de la oxidación de ácidos grasos en el recién nacido:Propiedades mixtas (sólo paneles):Punto temporal:gota de sangre (papel de filtro):-:
et-EE Estonian (Estonia) Rasvhapete oksüdatsioonidefektis sõeluuring vastsündinul:-:Pt:Vereplekk:-:
Synonyms: Juhuslik Veri
fr-FR French (France) Oxydation des acides gras dépistage néonatal panel:-:Ponctuel:Sang buvard:-:
fr-BE French (Belgium) Panel screening nouveau-né oxidation des acides gras:-:Temps ponctuel:Sang sur papier filtre:-:
it-IT Italian (Italy) Acidi grassi, panel di screening neonatale per ossidazione:-:Pt:Sangue.su carta da filtro:-:
Synonyms: Chimica Ossidazione degli acidi grassi Panel screening neonatale per ossidazione degli ac Punto nel tempo (episodio) Sangue Set di prescrizione chimica Spot sangue secco
nl-NL Dutch (Netherlands) vetzuuroxidatie pasgeborene screening panel:-:moment:gedroogde bloedspot:-:
pl-PL Polish (Poland) Panel przesiewowy noworodka utleniania kwasów tłuszczowych:-:punkt w czasie:sucha kropla krwi:-:
pt-BR Portuguese (Brazil) Oxidação de ácidos graxos painel da tela de recém-nascido:#N/A:Pt:SgPapel:-:
Synonyms: ; FA oxidation NB scn pnl; FAO; Point in time; Random; DBS; Filter paper; FP; Dried blood spot; Blood; WB; Whole blood; Scr; Scn; Scrn; Pnl; Pan; Panl; New born; Acd; Acids; PANEL.CHEMISTRY; PANEL.CHEMISTRY; Chemistry
ru-RU Russian (Russian Federation) Жирные кислоты окисление новорождённый скрин панель:-:ТчкВрм:Кр.Сух.капл:-:
Synonyms: Кровь Кровь сухая капля Точка во времени;Момент
zh-CN Chinese (China) 脂肪酸氧化新生儿筛查组套:-:时间点:全血.斑点:-:
Synonyms: FAO 全血斑点(滤纸);滤纸;血液.斑点;血液斑点(滤纸) 化学;化学检验项目;化学检验项目类;化学类;化学试验;非刺激耐受型化学检验项目;非刺激耐受型化学检验项目类;非刺激耐受型化学试验;非刺激耐受型化学试验类 医嘱套餐 医嘱套餐类 医嘱套餐组 医嘱组 医嘱组.化学试验;化学组套（组合、医嘱组、套餐、套餐医嘱、医嘱套餐、组合申请、组合项目）;化学医嘱组类;医嘱组.化学;医嘱组.化学检验项目;医嘱组类.化学;医嘱组类.化学检验项目;医嘱组类.化学试验;实验室医嘱组类.化学;实验室医嘱组类.化学检验项目;实验室医嘱组类.化学试验 医嘱组合 医嘱组合类 医嘱组套 医嘱组套类 医嘱组类 多重;多重型;多重标尺类型;多重精度类型 套餐 套餐医嘱 套餐医嘱组 套餐医嘱组类 实验室医嘱套餐 实验室医嘱套餐类 实验室医嘱组 实验室医嘱组合类 实验室医嘱组套 实验室医嘱组套类 实验室套餐医嘱组 实验室套餐医嘱组类 实验室检验项目医嘱组合类 实验室检验项目组合类 时刻;随机;随意;瞬间 检验医嘱组合类 检验项目医嘱组合类 检验项目组合类 筛查 筛查试验 筛选试验 组 组合 组合医嘱 组合类 组套 脂肪酸氧化新生儿筛查组套（组合、医嘱组、套餐、套餐医嘱、医嘱套餐、组合申请、组合项目）;脂肪酸氧化功能新生儿筛查医嘱组;脂肪酸氧化新生儿筛查组套;脂肪酸氧化新生儿筛查组合 血;血液 过筛 过筛试验 酸

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=57084-6
Questionnaire definition
https://fhir.loinc.org/Questionnaire/?url=http://loinc.org/q/57084-6